Variant ID: 1-55505665-TG-AT


This variant was identified in 1 publication

View GRCh38 version.


Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action.

Plos One
Sheridan, Douglas D; Yu, Zhao-Xue ZX; Zhang, Yuchun Y; Patel, Rekha R; Sun, Fang F; Lasaro, Melissa A MA; Bouchard, Keith K; Andrien, Bruce B; Marozsan, Andre A; Wang, Yi Y; Tamburini, Paul P
Publication Date: 2018

Variant appearance in text: PCSK9: L52H
PubMed Link: 29649283
Variant Present in the following documents:
  • Main text
View BVdb publication page